Why your pensions could be dealt a body blow as Donald Trump eyes devastating tariffs for Britain's top pharmaceutical firms - with thousands of jobs at risk: CALUM MUIRHEAD ○
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock market - and also rival GSK, another stalwart of the FTSE 100.